Search the hub
Showing results for tags 'Arthritis'.
-
Content Article
This briefing from Arthritis UK finds that almost a fifth (19%) of integrated care boards (ICBs) in England are rationing joint replacement surgery by disadvantaging patients with a higher body mass index (BMI). A further 54.7% have policies that restrict or alter access to surgery in some other way for those with overweight or obesity. Not only are these policies unfair, but they also contradict National Institute for Health and Care Excellence (NICE) guidelines and government policy. Arthritis UK is calling for all ICBs to stop using these policies and stop rationing surgery based on a person’s BMI.- Posted
-
- Surgery - Trauma and orthopaedic
- Obesity
- (and 3 more)
-
Event
untilThis virtual launch event celebrates the ARMA report Act Now: MSK Health inequalities and deprivation. • Hear about the findings of the report and what they mean for health services and healthcare professionals. • How does deprivation relate to MSK health? • What are the 5 steps to addressing health inequalities and what do they look like in practice? • What are the particular issues for children and young people? • What can you do to create change if you act now? Join the discussion with the panel: • Anthony Gilbert, Postdoctoral Clinical Research Physiotherapist, Royal National Orthopaedic Hospital NHS Trust • Shabir Aziz, Lived Experience Partner • Lesley Kay, National Clinical Director for MSK, NHS England • Jacqui Clinch, Consultant Paediatric Rheumatologist Register for the event- Posted
-
- Arthritis
- Health inequalities
-
(and 2 more)
Tagged with:
-
Content Article
ARMA Inquiry into MSK health inequalities
Patient_Safety_Learning posted an article in Health inequalities
The prevalence and impact of musculoskeletal conditions are not experienced equally across the population. Musculoskeletal conditions are linked to deprivation, age, are more prevalent in women, and disproportionately affect some minority ethnic groups.Deprivation is a significant driver of inequalities in MSK health. People in deprived areas experience more chronic pain, are more likely to have a long term MSK condition and experience worse clinical outcomes and quality of life.Between February and December 2023 the Arthritis and Musculoskeletal Alliance (ARMA) will deliver the first ever national inquiry into MSK health inequalities to explore and highlight the issues and make recommendations for improvement. The aims of the inquirySet out the evidence for inequalities in MSK health related to deprivation and explore the possible underlying reasons.Propose actions which can be taken to address these, both in design and delivery of MSK services, and actions to address wider determinants of health and prevention.Raise the profile of the issues and possible solutions. -
Event
untilSocial prescribing services and link workers have the potential to make a big difference to the lives of people with musculoskeletal conditions such as arthritis or back pain. This webinar hosted by the Arthritis and Musculoskeletal Alliance (ARMA) aims to help you understand musculoskeletal (MSK) conditions, their prevention, their impact, and how to consider this when you meet clients. Healthy bones, joints and muscles are fundamental to our ability to move, be active, work and engage in activities we enjoy. MSK health underpins our ability to live healthy and independent lives. MSK conditions are the single biggest cause of years lived with disability in the UK and the resulting pain and lack of mobility can have a huge impact on a person’s life. This webinar is aimed at people without a detailed knowledge of MSK conditions and will help you know how best to support people living with such conditions. It will cover: Common MSK conditions and their impact on daily life Self-management – what helps including physical activity, diet, weight and daily activities Mental health Work and education What patient organisations can offer A social prescribing perspective The webinar is designed to complement ARMA's guide for link workers and social prescribing services. Speakers: Wendy Holden, Arthritis Action Medical Advisor & Honorary Consultant Rheumatologist Sarah Holden, Head of Public Health Services, City Health Care Partnership CIC Shantel Irwin, Chief Executive, Arthritis Action ARMA would like to thank Arthritis Action for their support of this webinar. Register for this webinar -
Event
untilJoin the #SolvingTogether Connect Sessions, virtual sessions that anyone can attend where people share their ideas for addressing the challenges. They are informal opportunities to put forward ideas, and have discussion. Patients and health and care staff are all invited to attend. The MSTeams link to the session will be added to the event page at 9am on Thursday 2nd February.- Posted
-
- Surgery - General
- Arthritis
- (and 3 more)
-
Content Article
UK-based charity Versus Arthritis are campaigning to ensure that the needs of people with arthritis are prioritised by policymakers as plans for the COVID-19 recovery are developed. As part of this work, in this report they set out a six-part support package to help to meet the needs of people with arthritis who are on surgery waiting lists. This guide from Versus Arthritis was written in consultation with people with musculoskeletal conditions waiting for joint replacement surgery. It makes the case Integrated Care Systems, Primary Care Networks, secondary care providers, public health bodies and social care providers should all work together with local communities and the voluntary sector to deliver a support package to help to meet the needs of people with arthritis who are on surgery waiting lists. The six key elements of this are as follows: Clear communication must be provided to people with arthritis about when they can expect to have their surgery and receive the care and services they need in the meantime. Personalised self-management support must be provided to help people with arthritis manage their pain while they wait for surgery. Physical activity programmes designed to help people with arthritis stay active and prepare for surgery should be actively promoted by Primary Care Networks. Mental health support should be offered to help every person with arthritis to manage their pain and any associated depression and anxiety. Signposting to financial support and advice should be provided for people with arthritis in work or seeking work. Covid-19 recovery plans should include the specific needs of people with arthritis.- Posted
-
1
-
- Arthritis
- Long waiting list
-
(and 1 more)
Tagged with:
-
News Article
Children with arthritis 'facing delays to diagnosis'
Patient Safety Learning posted a news article in News
Delays diagnosing and treating children with arthritis are leaving them in pain and at a higher risk of lifelong damage, a national charity has warned. Arthritis is commonly thought to affect only older people, but 15,000 children have the condition in the UK. Versus Arthritis says many children are not getting help soon enough. The NHS said: "Arthritis in young people is rare and diagnosing it can be difficult because symptoms are often vague and no specific test exists." Zoe Chivers, Head of Services at Versus Arthritis, said: "We know that young people often face significant delays getting to diagnosis simply because even their GPs don't recognise that it's a condition that can affect people as young as two. It's often considered that they're just going through growing pains or they've just got a bit of a viral infection and that's not the case." Read full story Source: BBC News, 12 February 2020- Posted
-
- Arthritis
- Skill-based issue
- (and 2 more)
-
Content Article
Top 21 Chronic Pain & Illness Blogs (20 August 2021)
Patient-Safety-Learning posted an article in Patient stories
This article lists some of the top chronic pain and illness blogs on the internet, with a short description of each one.- Posted
- 1 comment
-
- ME/ Chronic fatigue syndrome
- Patient
-
(and 4 more)
Tagged with:
-
Content Article
In this anonymous blog, a patient explains how her experiences of pain were dismissed after the birth of her first baby. Although her own research indicated she had rheumatoid arthritis, she had to battle misinformed and unhelpful doctors to get a referral to a specialist. This led to delays in her diagnosis, leaving her questioning whether life would be different had she been listened to sooner. This blog has been published as part of a series for World Patient Safety Day 2024 and the theme of Improving diagnosis for patient safety. #WPSD24, World Patient Safety Day 2024, WPSD 2024. Debilitating pain dismissed Just over ten years ago I had my first baby. The first few weeks were the usual blur of excitement, recovery, getting to grips with feeding and endless night time nappy changes. In the middle of all of the upheaval, it was easy to miss the early twinges. But as the days went on I began to notice a sharp pain that radiated from my shoulder every time I picked up my baby. I just needed to learn to hold him better, I was told. But no number of cushions wedged under my elbow was helping. By the time my six-week check came along, I couldn’t manage the ten minute walk to our GP surgery. The joints in my hands and feet felt like they were full of glass and I knew something was seriously wrong. A friend took me and my son to my appointment in their car and I was hopeful that the GP could give me some answers. “Oh, everyone has pains after having a baby, it’s just that your joints are more floppy.” I was told to take ibuprofen—they were sure I’d feel better if I tried to keep active and build my muscle strength. I took on what the GP said, and left wondering if I was just making a fuss. But it turns out I wasn’t. The growing impact on life Every joint in my body was painful, all day, every day. I couldn’t sleep, couldn’t get myself out of bed and sometimes couldn’t drive because I couldn’t trust my wrists to change gears. I went back to the GP three more times in those months, to be told each time that my blood tests looked normal and it was just my joints sorting themselves out after pregnancy. I protested that surely it couldn’t be this painful, and be everywhere if that were the case, but was told to just keep an eye and come back if it didn’t go away. By June, I was desperate for some relief. The pain was horrible, but the thing that distressed me most was the impact it had on how I was able to look after my son. I developed special ways of lifting him, but couldn’t hold him for long periods of time. When he wasn’t at work, my partner did almost everything to care for our son and keep the house running. Fighting for a referral I had looked up rheumatoid arthritis (RA) in the past, as I had had some symptoms a few years earlier when I was at university in another city. At that time, I had been told by a GP that it couldn’t be RA as it was on both sides—I now know that to be completely false, as RA usually presents in the same joint on both sides of the body. As a student, I was told I had weak shoulders and was referred for physio. The pain had eventually passed on its own. I decided to look up my symptoms, which were now much worse, on the NHS website—they were absolutely classic signs of RA. I was alarmed to read that early diagnosis and treatment are vital to achieving remission. That certainly hadn’t happened for me! Armed with my new knowledge, I booked another GP appointment. This time I saw a different GP. After explaining my concerns and symptoms, I asked her to refer me to rheumatology for further tests. She barely looked at me. “I can refer you if you insist, but it won’t make any difference. You don’t have RA.” I was so shocked by her response that I didn’t say anything. I just took the referral letter, relieved to have what I needed. 9 months later: investigations finally began It took another three months to see a specialist—when I had my first consultant appointment I had been living with symptoms for nine months. The rheumatology consultant took one look at my hands and said, “Yes, that looks like RA.” But the rest of the conversation was confusing. He said he could see evidence of erosion on an x-ray, but that it may not be RA after all—he would need to run more tests. They took some more blood samples and I left with the impression that it could go either way. After a further three months, I had a follow up appointment, this time in a different hospital with a different doctor. She was very kind and made me feel at ease. But I was confused when she asked me, “So, are you ready to start on methotrexate?” I asked whether this meant I did have RA. “Oh, yes, of course. Didn’t anyone tell you?” The devastation and relief I remember feeling completely overwhelmed by finally having a diagnosis. It was both a relief, and devastating at the same time. I didn’t feel ready to make a decision about going on medication as it had implications for future pregnancies and carried other risks. Thankfully, the doctor gave me some information to read and a number to call if I decided I wanted to go for it—she would send a prescription to the hospital pharmacy for me to collect the next day. I was grateful to be given time and space to make the decision. However, I sensed her keenness that I get on methotrexate quickly, so after a week, I called and started treatment. The impact of diagnostic delay cannot be underestimated My symptoms and interactions with healthcare over that year had a deep impact on me. It affected my physical health in obvious ways, but it also had a negative impact on my mental health. The stress of knowing something is very wrong but feeling like no one who can help believes you is enormous. I felt like I’d missed out on precious experiences with my son. The decision over returning to work after maternity leave was taken out of my hands—there was no way I could have worked with the symptoms I was experiencing. What happened to me isn't unusual. Sadly the threads of my story have been experienced by so many people—having serious symptoms dismissed, not being told the results of tests and rudeness from healthcare professionals. I complained to the practice about the GP who had reluctantly referred me, outlining my concerns about how she had spoken to me, as well as the fact that her diagnosis had been wrong. What I received was a denial that she had used those words and an “I’m sorry you feel that way” apology. Sadly, it left me unconvinced that she would make any changes to her practice to stop the same thing happening to other patients. It took many years to find the right medication, but my RA is now under control. It does still affect many aspects of life, but I am able to work, look after my children and do things I never thought I’d do again, like camping and hiking! I also have a positive relationship with my current consultant and support is there if I need it. But I do sometimes wonder how different things might have been if my GP had investigated my symptoms during that six week check. Would I have been diagnosed sooner? Would the RA have progressed as far as it has? Would I have the complications I have today? Would I have ended up on such strong medication, probably for the rest of my life? I’ll never know the answer to these questions, but they have made me realise how important it is to push through when healthcare professionals dismiss your symptoms. Your intuition—and even your knowledge—might be correct. Share your experience Have you been affected by a late diagnosis? Or perhaps you have insights to share on diagnostic safety through the work that you do. If you would like to write a blog or share your thoughts, experiences or resources through the hub please get in touch with our team at [email protected] or add your comments to our community forum page.- Posted
-
- Diagnostic error
- Arthritis
-
(and 1 more)
Tagged with:
-
Content Article
Throughout 2023, the Arthritis and Musculoskeletal Alliance (ARMA) carried out the first ever national inquiry into musculoskeletal (MSK) health inequalities. The inquiry found that the prevalence and impact of musculoskeletal conditions are not experienced equally across the population. Musculoskeletal conditions are linked to deprivation and age, are more prevalent in women and disproportionately affect some ethnic groups. Deprivation is a significant driver of inequalities in MSK health. People in deprived areas experience more chronic pain, are more likely to have a long term MSK condition and experience worse clinical outcomes and quality of life. These inequalities are avoidable through changes in the design and delivery of MSK services, and actions to address wider determinants of health and prevention. The report makes recommendations to reduce health inequalities in MSK care, treatment and outcomes.- Posted
-
- Arthritis
- Surgery - Trauma and orthopaedic
- (and 6 more)
-
Content Article
The prevalence and impact of musculoskeletal conditions (MSK) are not experienced equally across the population. Musculoskeletal conditions are linked to deprivation and age, are more prevalent in women and disproportionately affect some minority ethnic groups. Although the issue of health inequalities is a current area of focus for the NHS, MSK receives a low profile in this work. This presentation by Liz Lingard, Delivery Partner for System Improvement at NHS England (North East & Yorkshire), looks at what drives inequalities in musculoskeletal health, and what can be done to address this.- Posted
-
- Arthritis
- Health inequalities
-
(and 2 more)
Tagged with:
-
Content Article
ARMA - MSK Health inequalities resources
Patient-Safety-Learning posted an article in Health inequalities
The Arthritis and Musculoskeletal Alliance (ARMA) has compiled relevant and useful resources and information specifically about musculoskeletal health inequalities. The resources include research studies, reports and reviews, and cover these areas: Social deprivation Ethnicity Sex, gender and sexual orientation Health literacy and education level Multiple factors Children and young people Webinars- Posted
-
- Arthritis
- Health inequalities
- (and 5 more)
-
Content Article
Serious pathology as a cause of musculoskeletal (MSK) conditions is considered rare, but it needs to be managed either as an emergency or as urgent onward referral as directed by local pathways. This guidance supports primary and community care practitioners in recognising serious pathology which requires emergency or urgent referral to secondary care in a patient who present with new or worsening MSK symptoms.- Posted
-
- Arthritis
- Medicine - Rheumatology
- (and 3 more)
-
Content Article
In England, around 10 million adults and 12,000 children have a musculoskeletal (MSK) condition. Ethnic minority groups, people from lower income households and those living in areas of high deprivation are most affected. In this guest blog for the Arthritis and Musculoskeletal Alliance (ARMA), Bola Owolabi, Director of the National Healthcare Inequalities Improvement Programme at NHS England, highlights the role that MSK health inequalities play in people's lives. She looks at the link between socio-economic disadvantage and poor health outcomes, and discusses the wider implications of disability due to MSK conditions. She describes work being done by the NHS, and highlights ARMA's work to narrow MSK health inequalities through listening to the experiences of underserved communities and working in partnership to improve care.- Posted
-
- Health inequalities
- Health Disparities
- (and 6 more)
-
Content Article
Chronic (persistent or long-lasting or recurrent) pain is life-changing and can significantly impact individuals, their families and carers. This paper sets out the Arthritis and Musculoskeletal Alliance's (ARMA's) position on how pain affects people with musculoskeletal conditions, and how their pain should be managed. In this paper, ARMA makes the following recommendations: Develop multidisciplinary, networked, personalised approaches to pain as standard. Develop more community-based approaches to pain. Everyone with chronic pain should be offered a holistic assessment of their symptoms in primary care reviewing the impact on their physical and mental health, their activities of daily living and their wellbeing, including the ability to work/study, and explore any underlying causes of or contributors to their pain. A public health approach is needed based on community need to design and target effective public health interventions to support those who have chronic pain to improve their health and their quality of life. Take a strategic, integrated population health approach to commissioning pain services ensuring money transcends organisational boundaries, focussed on the provision of a range of chronic pain support options and intervention allowing for personalisation. There should be early access to treatment for painful conditions to minimise pain becoming chronic, including rapid diagnosis, which is important to people. Integrated physical and mental health support for people with MSK pain conditions should be available and every CCG should include MSK chronic pain in IAPT for Long Term Conditions with staff who have joint expertise in both physical and mental health and understanding of chronic pain. Understand health inequalities, discuss and implement levers for change. Systems and services should allow equity in access, experience of using NHS services and equity of outcomes for all groups. Systems and services should be inclusive and culturally sensitivity. Social prescribing to provide supported self-management at scale. Every person with chronic pain should have access to peer support and be signposted to the patient organisations relevant to them. Healthcare professionals education and training to include understanding and management of pain and emphasise the personalised biopsychosocial approach and communications skills training to support them to have good conversations. Public education – including employers, public attitudes to increase health literacy and understanding of pain.- Posted
-
- Pain
- Underlying health conditions
- (and 5 more)
-
Content Article
Inflammatory rheumatic disease (IRD), such as rheumatoid arthritis, can cause poor outcomes in pregnancy, and the health of the mother and developing foetus must be balanced when making decisions about medication. This updated guideline from the British Society for Rheumatology contains evidence and best practice for prescribing rheumatology medications during pregnancy and breastfeeding. It includes a table that summarises information about drug compatibility in pregnancy and breastfeeding.- Posted
-
- Pregnancy
- Medicine - Rheumatology
-
(and 6 more)
Tagged with:
-
Content Article
This report of a roundtable held by the Arthritis and Musculoskeletal Alliance (ARMA) highlights inequalities in relation to the prevalence of, and access to treatment for musculoskeletal conditions (MSKs). MSKs include a broad range of health conditions affecting the bones, joints, muscles and spine, as well as rarer autoimmune conditions such as lupus. Their incidence is correlated with deprivation, age, sex and ethnicity. The report addresses MSK inequalities in the following categories: Digital access and health literacy Communities Prevention Children and young people Data Waiting lists Care gap Status of MSK- Posted
-
- Arthritis
- Medicine - Rheumatology
- (and 2 more)
-
Content Article
The National Early Inflammatory Arthritis Audit (NEIAA) aims to improve the quality of care for people living with inflammatory arthritis, collecting information on all new patients over the age of 16 in specialist rheumatology departments in England and Wales. This NEIAA report presents data describing the association between ethnicity, experience of care and clinician and patient-reported outcomes. It found that Black, Asian and ethnic minority patients were less likely to achieve remission at three months (30% compared to 37%) and were more likely to report symptoms of anxiety or depression compared to white patients (33% compared to 30%), despite faster referrals and assessments than white patients. Key findings of the report include: 47% of Black, Asian and ethnic minority patients and 43% of white patients were referred to rheumatology services within three working days of presenting (Quality statement 1) 43% of Black, Asian and ethnic minority patients and 42% of white patients were assessed within three weeks of referral 2013 version of QS33 (Quality statement 2) A higher proportion of Black, Asian and ethnic minority patients (60%) received timely treatment compared to white patients (57%) (Quality statement 2) A high proportion of both groups of patients were provided with disease-related education (93% of Black, Asian and ethnic minority patients and 94% of white patients) (Quality statement 3) A high proportion of both groups of patients were able to access care in case of emergencies (91% of Black, Asian and ethnic minority patients and 93% of white patients) (Quality statement 4) 34% of Black, Asian and ethnic minority patients and 46% of white patients received a formal annual review (Quality statement 5).- Posted
-
- Medicine - Rheumatology
- Arthritis
- (and 3 more)
-
News Article
Arthritis drug cuts Covid deaths, scientists discover
Patient Safety Learning posted a news article in News
A drug used to treat rheumatoid arthritis could cut the number of Covid deaths and speed up recovery, a new scientific trial has found. The drug, tocilizumab, could save the lives of one in 25 coronavirus patients in hospital and reduce the need for ventilators in intensive care. Researchers say around half of the people admitted to hospital with coronavirus could benefit from the treatment. Scientists from the nationwide Recovery trial said when tocilizumab was given alongside the steroid dexamethasone, it reduced the absolute risk of mortality by four percentage points. The medicine was already being used by the NHS to treat some coronavirus patients after early results last month showed it reduced the risk of death as well as time spent in hospital by up to 10 days. As a result of the latest findings, the health secretary said the drug would be made more widely available on the NHS to help treat Covid patients. Read full story Source: The Independent, 11 February 2021 -
News Article
People with arthritis told to exercise more and use painkillers less
Patient Safety Learning posted a news article in News
People with arthritis are being urged to lose weight and exercise more rather than rely on painkillers as the main therapies for their condition. NHS guidance from the National Institute for Health and Care Excellence (NICE) says people who are overweight should be told their pain can be reduced if they shed the pounds. Aerobic exercise such as walking, as well as strength training, can ease symptoms and improve quality of life. Exercise programmes may initially make the pain worse, but this should settle down, the guidance suggests. The guidelines also give recommendations on the use of medicines, such as offering non-steroidal anti-inflammatory drugs (NSAIDs) but not offering paracetamol, glucosamine or strong opioids. NICE said there was a risk of addiction with strong opioids, while evidence suggests little or no benefit for some medicines when it comes to quality of life and pain levels. The draft guidelines say people can be offered tailored exercise programmes, with the explanation “doing regular and consistent exercise, even though this may initially cause discomfort, will be beneficial for their joints”. Tracey Loftis, head of policy and public affairs at the charity Versus Arthritis, said: “We’ve seen first-hand the benefits that people with osteoarthritis can get in being able to access appropriate physical activity, especially when in a group setting. Something like exercise can improve a person’s mobility, help manage their pain and reduce feelings of isolation. “But our own research into the support given to people with osteoarthritis showed that far too many do not have their conditions regularly reviewed by healthcare professionals, and even fewer had the opportunity to access physical activity support. “The lack of alternatives means that, in many cases, many people are stuck on painkillers that are not helping them to live a life free from pain. “While we welcome the draft Nice guidelines, healthcare professionals need further resources and support to better understand their role in promoting treatment like physical activity for people with osteoarthritis. “There is clearly a need for people with arthritis to be given a bigger voice so that their health needs are not ignored.” Read full story Source: The Guardian, 29 April 2022 -
Content Article
Juvenile idiopathic arthritis (JIA) is an autoimmune disease that affects around 10,000 children aged under 16 in the UK. It is a chronic disease and many patients will continue to have JIA into adulthood. JIA causes inflammation, pain and stiffness in joints, and can be have a big impact on a child's life. This study by the National Confidential Enquiry into Patient Outcome and Death (NCEPOD) looked at the quality of care provided to patients diagnosed with JIA. Patients were randomly selected for inclusion in the peer review process if their diagnosis had been made between 1st April 2019 and 31st March 2023, and they were diagnosed or experienced symptoms before their 16th birthday. Data included 374 clinician questionnaires and the assessment of 290 sets of case notes. In addition, 122 organisational questionnaires were returned along with 130 primary care questionnaires, survey responses from 68 parents/carers and 117 healthcare professionals. The study report includes recommendations highlighting areas that are suitable for regular local clinical audit and quality improvement initiatives. Recommendations Raise awareness of juvenile idiopathic arthritis and its symptoms with the healthcare professionals who will see this group of patients. Streamline and publicise local referral pathways with clear measurable timelines for patients with suspected juvenile idiopathic arthritis. Provide timely access to appropriately trained physiotherapy, occupational therapy, pain and psychology services at the diagnosis of juvenile idiopathic arthritis, and then as needed through adolescence and adulthood. Offer age-appropriate information about juvenile idiopathic arthritis and medication risks and benefits to patients and their parents/carers at diagnosis and on an ongoing basis. Provide training to the patient, if age-appropriate, and/or their parents/carers on how to administer subcutaneous injections for juvenile idiopathic arthritis at the point treatment is initiated. Ensure timely access to intra-articular steroid injections by staff who have been trained to deliver age-appropriate care in units where local or general anaesthesia can be delivered. Provide a holistic, developmentally appropriate rheumatology service for patients with juvenile idiopathic arthritis. Develop NICE guidance for the management of juvenile idiopathic arthritis. -
Content Article
This study in Best Practice & Research Clinical Rheumatology aimed to determine the systemic effects of surgical mesh implants. The study looked at patients referred to an autoimmunity clinic between January 2014 and December 2017 and concluded that mesh implants may increase the risk of developing autoimmune diseases by acting as an adjuvant (increasing the body's own immune response).- Posted
-
- Medicine - Rheumatology
- Surgery - Obs & Gynae
- (and 4 more)
-
Content Article
NRAS - SMILE-RA e-learning for patients
Patient-Safety-Learning posted an article in Patient engagement
SMILE (Self-Management Individualised Learning Environment) is an e-learning experience for people with rheumatoid arthritis (RA) who want to learn more about RA, its treatments and how to become good at self-managing. Each module is on a particular theme or subject and takes between 20 mins and half an hour to complete. Current modules available: Foundation Newly diagnosed Meet the team Managing pain and flares A module on Medicines and Treatment (to be launched)- Posted
-
- Patient engagement
- Medicine - Rheumatology
-
(and 3 more)
Tagged with:
-
Content Article
In this blog, Dr Chloe Stewart, health psychologist and national clinical advisor in personalised care for NHS England, looks at the role of personalised care in helping overcome the care backlog and addressing health inequalities in people with musculoskeletal conditions (MSKs). She looks at examples of coproduction in MSK services and highlights the need to give patients better information and training about how to manage their condition.- Posted
-
- Arthritis
- Patient engagement
-
(and 2 more)
Tagged with: